D Chassard

758 total citations
34 papers, 573 citations indexed

About

D Chassard is a scholar working on Pharmacology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, D Chassard has authored 34 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Molecular Biology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in D Chassard's work include Pharmacogenetics and Drug Metabolism (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Dermatology and Skin Diseases (3 papers). D Chassard is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Dermatology and Skin Diseases (3 papers). D Chassard collaborates with scholars based in France, Canada and United States. D Chassard's co-authors include F. Chauffard, Marc Enslen, Denise Batéjat, D. Lagarde, Nathalie Chabbert‐Buffet, Sophie Christin‐Maître, X. Combes, Gilles Dhonneur, Thomas Bossmar and Mats Åkerlund and has published in prestigious journals such as Gastroenterology, Human Reproduction and SLEEP.

In The Last Decade

D Chassard

34 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Chassard France 14 131 127 76 60 59 34 573
Jennifer R. Baker Australia 19 77 0.6× 113 0.9× 78 1.0× 257 4.3× 93 1.6× 48 1.1k
G.W. Dawson Australia 9 50 0.4× 116 0.9× 30 0.4× 161 2.7× 35 0.6× 13 607
Graham Read United Kingdom 14 66 0.5× 147 1.2× 11 0.1× 111 1.9× 29 0.5× 22 621
Stefano Milleri Italy 17 111 0.8× 49 0.4× 66 0.9× 188 3.1× 12 0.2× 37 747
M. Yusoff Dawood United States 12 112 0.9× 369 2.9× 40 0.5× 41 0.7× 326 5.5× 15 725
R. A. A. Maes Netherlands 17 100 0.8× 32 0.3× 27 0.4× 177 3.0× 20 0.3× 32 788
Janice Paiker South Africa 16 18 0.1× 243 1.9× 62 0.8× 112 1.9× 37 0.6× 25 939
G. Del Rió Italy 15 37 0.3× 102 0.8× 24 0.3× 91 1.5× 36 0.6× 43 722
Susan E. Kimmel United States 20 115 0.9× 48 0.4× 18 0.2× 46 0.8× 6 0.1× 27 1.4k
Cristiana Gambelunghe Italy 17 102 0.8× 107 0.8× 24 0.3× 134 2.2× 5 0.1× 50 1.1k

Countries citing papers authored by D Chassard

Since Specialization
Citations

This map shows the geographic impact of D Chassard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Chassard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Chassard more than expected).

Fields of papers citing papers by D Chassard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Chassard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Chassard. The network helps show where D Chassard may publish in the future.

Co-authorship network of co-authors of D Chassard

This figure shows the co-authorship network connecting the top 25 collaborators of D Chassard. A scholar is included among the top collaborators of D Chassard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Chassard. D Chassard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brossard, Patrick, et al.. (2013). Effects of ponesimod, a selective S1P1 receptor modulator, on the pharmacokinetics of a hormonal combination contraceptive. European Journal of Clinical Pharmacology. 70(3). 287–293. 15 indexed citations
2.
3.
Chabbert‐Buffet, Nathalie, et al.. (2011). Inhibition of ovulation by NOMAC/E2, a novel monophasic oral contraceptive combining nomegestrol acetate and 17β-oestradiol: A double-blind, randomised, dose-finding pilot study. The European Journal of Contraception & Reproductive Health Care. 16(2). 76–84. 27 indexed citations
4.
5.
Patat, Alain, Virginia Parks, Sangeeta Raje, et al.. (2009). Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects. British Journal of Clinical Pharmacology. 67(3). 299–308. 17 indexed citations
6.
Krösser, Sonja, et al.. (2007). Investigation of the impact of sarizotan on the pharmacokinetics of levodopa. Biopharmaceutics & Drug Disposition. 28(7). 339–347. 9 indexed citations
7.
Puozzo, C., P Hermann, & D Chassard. (2006). Lack of pharmacokinetic interaction when switching from fluoxetine to milnacipran. International Clinical Psychopharmacology. 21(3). 153–158. 9 indexed citations
8.
Chassard, D & B Schatz. (2005). Activité antigonadotrope de l'acétate de chlormadinone chez la femme en période d'activité génitale. Gynécologie Obstétrique & Fertilité. 33(1-2). 29–34. 8 indexed citations
9.
Dhonneur, Gilles, et al.. (2004). Skin Sensitivity to Rocuronium and Vecuronium: A Randomized Controlled Prick-Testing Study in Healthy Volunteers. Anesthesia & Analgesia. 98(4). 986–989. 45 indexed citations
10.
Chassard, D, et al.. (2004). Bioequivalence Study of Two Ibuprofen Formulations Administered Intravenously in Healthy Male Volunteers. Clinical Drug Investigation. 24(12). 739–747. 5 indexed citations
11.
12.
Thomsen, Mikael S., et al.. (2003). Pharmacokinetics of Repaglinide in Healthy Caucasian and Japanese Subjects. The Journal of Clinical Pharmacology. 43(1). 23–28. 12 indexed citations
13.
Gaillard, S., et al.. (2002). Safety and Pharmacokinetics of P792, a New Blood-Pool Agent. Investigative Radiology. 37(4). 161–166. 25 indexed citations
14.
Debon, Richard, Dominique Breilh, Emmanuel Boselli, et al.. (2002). Pharmacokinetic Parameters of Ciprofloxacin (500 mg/5 mL) Oral Suspension in Critically Ill Patients with Severe Bacterial Pneumonia: A Comparison of Two Dosages. Journal of Chemotherapy. 14(2). 175–180. 10 indexed citations
15.
Beaumont, Maurice, Denise Batéjat, Christophe Piérard, et al.. (2001). Slow release caffeine and prolonged (64‐h) continuous wakefulness: effects on vigilance and cognitive performance. Journal of Sleep Research. 10(4). 265–276. 82 indexed citations
16.
Brouard, R., et al.. (2000). Effect of SR49059, an orally active V1a vasopressin receptor antagonist, in the prevention of dysmenorrhoea. BJOG An International Journal of Obstetrics & Gynaecology. 107(5). 614–619. 50 indexed citations
17.
Deprez, Dominique, et al.. (1998). Which bioequivalence study for a racemic drug? Application to milnacipran. European Journal of Drug Metabolism and Pharmacokinetics. 23(2). 166–171. 13 indexed citations
18.
Pussard, Eric, et al.. (1994). Pharmacokinetics and metabolism of amopyroquin after administration of two doses of 6 mg/kg im 24 h apart to healthy volunteers. Journal of Antimicrobial Chemotherapy. 34(5). 803–808. 4 indexed citations
19.
Montay, Guy, René Bruno, J. Vergniol, et al.. (1994). Pharmacokinetics of Sparfloxacin in Humans After Single Oral Administration at Doses of 200, 400, 600, and 800 mg. The Journal of Clinical Pharmacology. 34(11). 1071–1076. 34 indexed citations
20.
Montay, Guy, Y. Le Roux, A. Le Liboux, et al.. (1991). Comparative Bioavailability Study of Cefixime Administered as Tablets or Aqueous Solution. Drugs. 42(Supplement 4). 6–9. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer R. Baker Breakdown of academic impact, for papers by G.W. Dawson Breakdown of academic impact, for papers by Graham Read Breakdown of academic impact, for papers by Stefano Milleri Breakdown of academic impact, for papers by M. Yusoff Dawood Breakdown of academic impact, for papers by R. A. A. Maes Breakdown of academic impact, for papers by Janice Paiker Breakdown of academic impact, for papers by G. Del Rió Breakdown of academic impact, for papers by Susan E. Kimmel Breakdown of academic impact, for papers by Cristiana Gambelunghe
Rankless by CCL
2026